Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol

BACKGROUND: Warfarin and similar vitamin K antagonists have been the standard therapy for patients with mechanical or biological valve prosthesis and atrial fibrillation (AF). Even with the appropriate use of therapy, some studies have reported that there is a high incidence of thromboembolic events...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Duraes, Andre Rodrigues, Roriz, Pollianna DS, Bulhoes, Fabio V, Nunes, Bianca DA, Muniz, Juliana QV, Neto, Italvar NDCR, Fernandes, Andre MS, Reis, Francisco JFBD, Camara, Edmundo JN, Junior, Erenaldo DSR, Segundo, Deusdeth TS, Silva, Felipe Pinho E Albuquerque, Aras, Roque
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: JMIR Publications Inc. 2014
Konular:
Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004148/
https://ncbi.nlm.nih.gov/pubmed/24691436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/resprot.3014
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller